Agenus (AGEN) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

AGEN Agenus

Watchlist

3.400
-0.150-4.23%

Close Jan 8 16:00 ET

80.28MMarket Cap-0.31P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

$960 Mn Vaccine Adjuvants Market by Product, ROA, Disease Type, Vaccine - Global Forecast to 2029 With GSK, Seppic, Croda, SPI Pharma, Phibro Animal Health, Agenus, Dynavax Technologies Dominating
Yahoo FinanceJan 8 09:32 ET
B.Riley Financial Maintains Agenus(AGEN.US) With Buy Rating, Maintains Target Price $11
Moomoo NewsJan 7 08:31 ET · Ratings
Express News | Agenus Announced Five Presentations Featuring Botensilimab (Bot, An Fc-enhanced Anti-CTLA-4 Antibody) Plus Balstilimab (Bal, An Anti-PD-1 Antibody) At The Upcoming American Society Of Clinical Oncology Gastrointestinal Cancers Symposium
BenzingaDec 18, 2024 07:35 ET
H.C. Wainwright Maintains Agenus(AGEN.US) With Hold Rating
Moomoo NewsDec 5, 2024 12:35 ET · Ratings
Express News | HC Wainwright & Co. Reiterates Neutral on Agenusto Neutral
BenzingaDec 5, 2024 11:12 ET
Agenus Announces Strategic Realignment
TipRanksDec 5, 2024 07:35 ET

Comments

Trytosaveabit

Dec 18, 2024 06:40

Update

$Agenus (AGEN.US)$ Benzinga· 3 mins ago
Agenus Announced Five Presentations Featuring Botensilimab (Bot, An Fc-enhanced Anti-CTLA-4 Antibody) Plus Balstilimab (Bal, An Anti-PD-1 Antibody) At The Upcoming American Society Of Clinical Oncology Gastrointestinal Cancers Symposium

Jaguar8

Dec 5, 2024 06:32

NEWS

$Agenus (AGEN.US)$
Agenus Announces Strategic Realignment to Focus on Core Programs and Significantly Reduce Costs
1 minute ago, 4:30 AM PST
Via BusinessWire
Agenus Inc., a leader in immuno-oncology, today announced further details of its strategic realignment aimed at streamlining operations, strengthening its financial position, and prioritizing the advancement of its most impactful programs as it prepares for 2025. Reductions are designed to reduce cash burn to $100 million in FY 2025. T...

Jaguar8

Nov 27, 2024 07:15

NEWS

$Agenus (AGEN.US)$
Agenus Secures $22 Million Mortgage and Announces Strategic Operational Realignment
Agenus (NASDAQ: AGEN) has secured a $22 million mortgage backed by its Berkeley and Vacaville properties, providing $20 million in net proceeds.
The two-year mortgage includes interest payable 50% in cash and 50% in common stock, at rates of 12% for Year 1 and 13% for Year 2.
The company announced a Strategic Operational Realignment Plan focusing on botensilimab/balstilimab(BOT/BAL) in MSS...

Martin J

Nov 22, 2024 10:50

🚀🚀🚀

Share Your Profit/Loss

Jaguar8

Nov 7, 2024 09:02

NEWS

$Agenus (AGEN.US)$
Agenus to Present Compelling Data on Botensilimab and AGEN1721 at SITC 2024
Agenus (NASDAQ: AGEN) will present new data on two promising immunotherapy candidates at the SITC 2024 Annual Meeting in Houston. The presentations will feature botensilimab, an Fc-enhanced anti-CTLA-4 antibody showing efficacy in treatment-resistant cancers, and AGEN1721, a first-in-class bifunctional antibody targeting FAP and TGFβ.
Botensilimab enhances both innate and adaptive immunity, demonstr...

Heat List

Overall

No Data